Indo Us Biotech Limited Financial Ratios
INDOUS · Fast Moving Consumer Goods · Current price ₹71.99
P/E ratio
11.0x
P/B ratio
1.7x
ROE
14.2%
ROCE
12.5%
Debt / Equity
0.40
Dividend yield
0.3%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 11.0x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 1.7x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 14.2% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 12.5% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.40 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Indo Us Biotech Limited's latest numbers.
Indo Us Biotech Limited profitability
Indo Us Biotech Limited generates a return on equity of 14.2% and a return on capital employed of 12.5%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.40 and a P/E of 11.0x, Indo Us Biotech Limited is conservatively financed. Our overall business-quality score for the company is 5.7 / 10.
Understand the ratios
More on Indo Us Biotech Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.